U.S. Markets open in 9 hrs 2 mins

Enanta Pharmaceuticals, Inc. (ENTA)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
37.54+0.43 (+1.16%)
At close: 4:00PM EDT
People also watch
EPZMFPRXXLRNMGNXOMED
Full screen
Previous Close37.11
Open36.86
Bid34.00 x 100
Ask37.85 x 200
Day's Range36.69 - 37.68
52 Week Range20.79 - 37.68
Volume236,843
Avg. Volume178,896
Market Cap716.39M
Beta1.01
PE Ratio (TTM)-53.94
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube12 days ago

    ETFs with exposure to Enanta Pharmaceuticals, Inc. : June 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Enanta Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ENTA-US. Comparing the performance and risk of Enanta Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Enanta Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ENTA-US : June 13, 2017
    Capital Cube13 days ago

    Enanta Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ENTA-US : June 13, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Enanta Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Enanta Pharmaceuticals, Inc. :ENTA-US: Earnings Analysis: Q2, 2017 By the Numbers : June 9, 2017
    Capital Cube17 days ago

    Enanta Pharmaceuticals, Inc. :ENTA-US: Earnings Analysis: Q2, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Enanta Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Enanta Pharmaceuticals, Inc. – Achillion Pharmaceuticals, Inc., Enzon Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated, SciClone Pharmaceuticals, Inc., AbbVie, Inc., Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company ... Read more (Read more...)